Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.
Senior Associate, Seed Fund and Doctors Innovate Fund
Drew Wandzilak
Senior Associate, Green D and Yard and Strategic Tech Fund
Sarah Worden
Venture Scout
Ray Wu
Managing Partner-Web3 / Blockchain Fund
Michael Yuann
Director of Investment Operations
Past deals in Healthcare
Salvo Health
Seed Round in 2025
Salvo Health is a virtual health clinic that specializes in treating chronic gut conditions. The company enhances access to specialized healthcare for individuals suffering from these conditions through its app-based platform. Salvo Health utilizes a proprietary approach known as Whole Self Science, which considers various health factors beyond just gastrointestinal issues. This comprehensive model allows healthcare providers to identify the root causes of chronic illnesses and develop personalized, ongoing treatment strategies tailored to each patient's needs. By focusing on individualized care, Salvo Health aims to improve the overall well-being of those with chronic gut-related illnesses.
Aescape
Venture Round in 2025
Aescape, Inc., founded in 2017 and based in New York, is a technology company focused on enhancing massage therapy and wellness experiences through innovative, data-driven solutions. The company develops robotics-driven technology that automates soft tissue treatments and integrates artificial intelligence to provide personalized wellness experiences. By combining cutting-edge research with a user-friendly interface, Aescape aims to address the growing demand for physical wellness and recovery solutions suitable for everyone, from elite athletes to fitness newcomers. The company also seeks to support massage therapists and athletic trainers by offering a scalable and reliable tool that mitigates labor shortages in the industry. Ultimately, Aescape's mission is to foster a deeper relationship between individuals and their bodies, improving overall well-being.
The Helper Bees
Series C in 2025
The Helper Bees, Inc. is a company based in Austin, Texas, that operates a platform connecting seniors with local caregivers for a variety of home care services across the United States. Founded in 2015, the platform allows seniors to find and hire helpers for tasks such as light housekeeping, grocery shopping, transportation to appointments, companionship, and specialized care for conditions like Alzheimer’s, dementia, and diabetes. The Helper Bees aims to enhance the home care experience by collaborating with major insurance carriers, utilizing digital solutions and machine learning to streamline care options and improve claim processing. This focus on technology and direct access to caregivers helps families navigate the complexities of home care, ensuring that seniors receive the support they need.
Springbok Analytics
Series A in 2025
Springbok Analytics offers an AI-powered software platform that transforms MRIs into three-dimensional analyses of muscle to enable true precision. Springbok Analytics' advanced imaging technology identifies and measures each individual muscle, providing data to scientists, physical therapists, athletic trainers, and physicians to evaluate muscle function in relation to performance and injury management. The technology has numerous applications, including injury management, performance enhancement, and the treatment of musculoskeletal conditions.
Torch
Venture Round in 2025
Torch Dental offers an all-in-one technology platform that addresses the supply ordering and inventory management needs of dental practices. By digitizing and optimizing traditional manual processes, Torch Dental simplifies the ordering experience for dental professionals. This allows dentists to dedicate more time to patient care rather than administrative tasks. The company's focus is on enhancing operational efficiency within dental practices, ultimately benefiting both practitioners and their patients.
Precision Neuroscience
Series C in 2024
Precision Neuroscience is a company focused on developing advanced brain-computer interface technology aimed at offering innovative treatments for the approximately one billion individuals worldwide affected by neurological disorders. Founded in 2021 and based in New York, the company's technology is characterized by its minimally invasive design, safety for removal, and capacity for processing substantial data. This platform enables medical professionals to establish a direct connection between the human brain and artificial intelligence, potentially transforming the landscape of neurological care.
Lōvu
Pre Seed Round in 2024
Lōvu Health is a digital health company specializing in maternal care. It provides a platform that supports mothers and babies from conception through to postpartum, using AI to deliver real-time analytics and evidence-based insights. The platform monitors vital signs like fetal heart rate and blood pressure, offers personalized recommendations, and sends action-oriented alerts, empowering users with reliable information and expert knowledge.
Canid
Series A in 2024
Canid is a company focused on enhancing the vaccination process for pediatricians by streamlining vaccination record management. Its innovative scanning system reduces the need for manual data entry, facilitating the automatic upload of vaccination information into state registries. The company's dashboard and process tools provide administrative consulting, ensure vaccine margins, automate workflow, and manage vaccine inventory. This comprehensive approach allows state officials and pediatric practitioners to concentrate on their core responsibilities, ultimately improving efficiency in vaccination administration.
Andromeda Surgical
Seed Round in 2024
Andromeda Surgical is a developer of autonomous robots designed to enhance the consistency, accuracy, and efficiency of surgical procedures. The company's open platform focuses on urologic procedures that have demonstrated superior outcomes but face challenges in widespread adoption due to technical complexities. By addressing these difficulties, Andromeda Surgical aims to empower surgeons to perform various procedures at a level typically achieved only by experts, thereby improving patient care and surgical success rates.
CytoVale
Series D in 2024
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.
Beam
Venture Round in 2024
Beam Technologies Inc. is a dental benefits company based in Columbus, Ohio, founded in 2012. It specializes in providing digital-first dental insurance plans that emphasize preventive care and ease-of-use. Beam’s offerings include dental insurance, which features perks such as floss, toothpaste, and the Beam Brush—a wirelessly connected toothbrush that allows users to track and monitor their brushing habits through a smartphone app. The company incorporates rewards for maintaining good dental hygiene into its policy pricing, making it a unique player in the dental benefits market.
Centaur Labs
Series B in 2024
Centaur Labs specializes in medical data annotation services, aimed at enhancing medical decision-making and diagnostics. The company utilizes a platform that connects a global network of students and professionals, who compete to provide high-quality data labeling. This collaborative model ensures exceptional accuracy and scalability in annotating medical and scientific data. By analyzing medical cases and labeling data effectively, Centaur Labs contributes to the development of advanced medical AI technologies, ultimately helping patients achieve better healthcare outcomes while potentially reducing costs.
Bionic Health
Seed Round in 2024
Bionic Health is a digital healthcare company focused on providing preventative health services, particularly for individuals experiencing chronic pain. The company has developed a platform that utilizes frequent diagnostics and machine learning to create personalized treatment plans. This approach emphasizes slowing down the aging process and offers patients tailored insights derived from ongoing assessments. By implementing an iterative journey, Bionic Health enables users to identify their unique health needs and make impactful lifestyle changes over time. Additionally, patients benefit from closely monitored preventative care throughout the year, enhancing their overall well-being.
Syntra
Pre Seed Round in 2024
Syntra develops an EHR platform that streamlines billing, records, and follow-ups, helping doctors automate tasks.
AminoChain
Seed Round in 2024
AminoChain operates a blockchain-based platform that enhances the management of biosamples by connecting data from healthcare companies. The platform allows users to oversee bio-sample inventories while ensuring ownership of their assets. It facilitates collaboration among stakeholders through an integrated solution that encompasses sample procurement, agreements, and payments. Additionally, AminoChain focuses on tokenizing and incentivizing stem cell donations, providing donors with compensation for their contributions and offering biobanks a secure method for inventory management.
GC Therapeutics
Series A in 2024
GC Therapeutics specializes in synthetic biology to efficiently program patient-derived stem cells into various cell types. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, enabling streamlined manufacturing and improved quality of cell therapies. Their approach allows for the rapid differentiation of pluripotent stem cells, creating unique SuperCells™ customized for specific medical conditions. The foundational technology was developed in Professor George Church's lab at Harvard Medical School, and the team at GC Therapeutics comprises dedicated biologists and tissue engineers focused on translating this innovative method into practical therapies for patients.
Kindbridge Behavioral Health
Pre Seed Round in 2024
Kindbridge Behavioral Health provides individual therapy, family therapy, group services, pricing, and insurance services. They provide treatments for depression, anxiety, gaming, stress, relationships, PTSD, family conflicts, mood disorders, gambling, trauma, addiction, dissociative disorders, and ADHD.
Clarium Health
Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.
MD Ally
Series A in 2024
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.
Hopscotch Primary Care
Series C in 2024
Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.
Grayce
Series A in 2024
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized support for families and employees managing the care of aging adults and children. Established in 2019, Grayce offers a comprehensive range of services, including assistance with insurance, finances, legal plans, medical care, home care, housing, and daily needs. The company emphasizes individualized guidance, ensuring that each member receives dedicated support from a social worker who helps manage their overall care. This includes planning, resource identification, care coordination, and advocacy, empowering family caregivers to effectively navigate the complexities of caring for their loved ones.
Shape
Seed Round in 2024
Shape specializes in developing a 3D body scanning system that allows users to digitally measure and visualize their body composition in photorealistic detail. Utilizing advanced technologies such as artificial intelligence and computer vision, Shape provides accurate assessments of body metrics that traditional methods cannot capture, including regional volume and changes in body composition. The system offers personalized insights and guidance based on individual user data, helping users track fat loss and muscle gains in an engaging manner. By delivering fast and gamified feedback, Shape aims to transform how individuals approach their health and fitness goals, enhancing motivation and progress tracking.
ParcelBio
Seed Round in 2024
ParcelBio is a biotechnology company specializing in the development of a novel, programmable method for safely and precisely delivering messenger RNA (mRNA) to diverse cell types within the body. Their technology aims to create targeted, potent, and durable RNA therapeutics, with the potential to treat a wide range of diseases, including cancer, genetic disorders, and infectious diseases.
Nanochon
Seed Round in 2024
Nanochon is focused on creating innovative implantable medical devices designed to address cartilage damage in joints. Utilizing advanced 3D printing techniques and a unique nanomaterial, the company aims to develop solutions that not only replace lost and damaged cartilage but also promote the growth of new tissue. This approach allows medical practitioners to access cost-effective and on-demand devices that enhance treatment outcomes, particularly for young and active patients suffering from knee injuries and diseases. Through its technology, Nanochon seeks to improve the overall quality of care in orthopedics.
Clarity Pediatrics
Seed Round in 2024
Clarity Pediatrics is focused on transforming pediatric chronic care, particularly for children diagnosed with Attention-deficit/hyperactivity disorder (ADHD), which affects nearly 10% of American children. The company has developed a virtual pediatric ADHD clinic that utilizes a tech-enabled platform to deliver high-quality care to families. This platform includes features such as video conferencing, secure messaging, and electronic health records, allowing for accessible and efficient communication. Clarity Pediatrics aims to provide trusted care that is backed by scientific research, with the goal of achieving exceptional health outcomes that can significantly improve a child's developmental trajectory. By leveraging technology, the clinic seeks to reach a broader market of families, irrespective of their location or insurance status, ensuring that children receive the necessary support and resources.
Nectero Medical
Series D in 2024
Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, that focuses on treating mid-sized abdominal aortic aneurysms. Founded in 2017, the company has developed an innovative treatment designed to stabilize the growth of aneurysms and prevent their rupture. This treatment delivers a compound containing a stabilizer agent directly to the aneurysm site, which helps inhibit further breakdown and strengthens the vessel wall. By providing a safer intervention option, Nectero Medical aims to enable patients to receive timely care, significantly delaying or preventing the need for major endovascular or surgical repair.
HelixNano
Series A in 2024
HelixNano is a biotechnology company focused on leveraging artificial intelligence and synthetic biology to develop innovative solutions for genetic diseases. Initially concentrating on cancer vaccines, the company is now pivoting to create COVID-19 vaccine candidates that prioritize precision and safety. HelixNano's platform enables the reliable expression of transgenes in humans, facilitating advancements in gene therapies and genome engineering. The company aims to not only address the current COVID-19 pandemic but also to develop vaccines that provide protection against all future coronaviruses. Through its work, HelixNano seeks to enable previously unattainable applications in both human and non-human biology, ultimately improving patient outcomes across a range of diseases.
Century Health
Pre Seed Round in 2024
Century Health is a technology company that specializes in accelerating drug development and commercialization. It achieves this by harnessing the power of artificial intelligence (AI) to analyze real-world clinical data, which is often siloed and difficult to access. The company's platform connects to various disease-specific datasets, cleans and standardizes the data using AI, and enables researchers to efficiently analyze this real-world data. This process helps answer critical questions more rapidly, supports the research community, and ensures patient privacy is protected.
Torch
Venture Round in 2024
Torch Dental offers an all-in-one technology platform that addresses the supply ordering and inventory management needs of dental practices. By digitizing and optimizing traditional manual processes, Torch Dental simplifies the ordering experience for dental professionals. This allows dentists to dedicate more time to patient care rather than administrative tasks. The company's focus is on enhancing operational efficiency within dental practices, ultimately benefiting both practitioners and their patients.
Nest Health
Seed Round in 2024
Nest Health is a family healthcare platform that provides a range of medical services aimed at reducing the stress associated with traditional healthcare arrangements. The company specializes in delivering in-home and virtual visits for patients of all ages, including newborns, children, teens, and adults. Their offerings encompass preventive care, sick visits, behavioral health support, nutrition guidance, and chronic disease management. By enabling patients to receive care in the comfort of their homes, Nest Health seeks to enhance accessibility and convenience in healthcare delivery.
BE Therapeutics
Seed Round in 2024
BE Therapeutics is a biotechnology company specializing in regenerative medicine. It develops innovative therapies aimed at repairing and restoring damaged brain and spinal cord tissue, focusing on engineering functional tissue to treat neurological conditions and spinal cord injuries.
Pendulum Therapeutics
Series C in 2024
Pendulum Therapeutics Inc. is a microbiome-focused company based in San Francisco that specializes in developing medical probiotics and prebiotics aimed at managing chronic illnesses, particularly type 2 diabetes. The company's flagship product, Pendulum Glucose Control, was introduced in 2020 and has demonstrated effectiveness in lowering blood sugar spikes and reducing A1C levels, as evidenced by published clinical trials. Pendulum utilizes evidence-based microbiome science and DNA sequencing to create targeted interventions, allowing clinicians to identify specific microbiome markers for disease treatment. Founded in 2013, Pendulum holds 13 patents and has 42 pending, with significant backing from prominent investors. The company sells its products online, focusing on improving healthcare through innovative microbiome therapies.
Alvee
Seed Round in 2024
Alvee is a developer of an artificial intelligence-driven tool designed to enhance health equity and improve health outcomes for patients. The tool offers real-time, patient-specific alerts that notify healthcare providers and payers when a patient has a confirmed or potential health equity issue. By integrating social determinants of health, chronic conditions, demographic information, and health inequity risks, Alvee provides a comprehensive view of a patient's health equity status. This enables healthcare providers and payers to meet data stratification quality reporting requirements effectively.
Piction Health
Seed Round in 2024
Piction Health is a dermatology care service that provides patients with rapid access to expert dermatological consultations for skin, hair, or nail concerns. Through its application, the company facilitates a streamlined process where patients receive a diagnosis and personalized care plan within two days. Piction Health employs artificial intelligence to enhance the experience for both patients and healthcare providers, enabling primary care physicians to obtain quick second opinions on complex skin conditions. This approach not only improves patient outcomes but also reduces unnecessary repeat visits and ineffective treatments, ultimately accelerating access to high-quality dermatology care from the comfort of home.
Arise
Seed Round in 2024
Arise is a provider of virtual care services focused on supporting individuals with eating disorders, a condition that affects a diverse range of people, yet often goes untreated. The company seeks to address the barriers and stigma associated with these disorders by expanding access to inclusive care through its innovative platform. This platform offers virtual therapy sessions with licensed therapists and dietitians, as well as support from care advocates who assist users in managing daily challenges. By fostering a community and providing ongoing support, Arise aims to deliver a new approach to healing that prioritizes both physical and mental health for those struggling with eating disorders.
Earli
Series A in 2024
Earli is a company focused on developing innovative cancer treatment devices that utilize synthetic biomarkers for early cancer detection. The company's approach involves a novel gene therapy technique known as Synthetic Biopsy, which prompts cancer cells to produce synthetic, non-human biomarkers. These biomarkers can be detected through various means, including blood, urine, or breath, allowing for timely tracking and treatment of cancer. By facilitating the early identification of cancer when it is still homogeneous, Earli aims to significantly enhance survival rates. Their technology not only aids in detection but is also applicable for therapeutic interventions, thereby personalizing treatment and improving patient outcomes.
Featureform
Seed Round in 2023
Featureform develops machine learning tools specifically for pharmaceutical and biotechnology companies. The company offers an open-source virtual feature store that enables data scientists to define, manage, and serve machine learning features throughout their organizations. Its platform provides a unified interface to connect, transform, and join both streaming and batch data. Featureform facilitates the discovery and integration of features created by various teams, allowing them to share and enhance their models. Additionally, the platform includes capabilities to monitor and analyze features, as well as to freeze them, which allows teams to concentrate on building models to support their data pipelines effectively.
Radix Health
Pre Seed Round in 2023
Radix Health is a platform that integrates the healthcare industry with market-based pricing, utilizing software and data engineering.
Clarium Health
Seed Round in 2023
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.
DocStation
Seed Round in 2023
DocStation, Inc. is a cloud-based patient care platform designed for pharmacists, incorporated in 2017 and headquartered in Austin, Texas. The platform connects payers and pharmacists to facilitate value-based programs, aiming to reduce healthcare costs while enhancing patient outcomes. With over 500 providers collaborating with innovative health plans, DocStation equips pharmacists with tools that streamline patient management. Its comprehensive dashboard allows for the maintenance of current diagnoses, medications, immunizations, and allergies, while also facilitating the creation of care plans, monitoring adherence, and scheduling follow-ups. By enabling real-time connections between pharmacists and patients, DocStation supports a shift towards value-based care in the pharmacy sector.
CytoVale
Series C in 2023
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.
Jona
Seed Round in 2023
Jona is a technology startup focused on leveraging artificial intelligence to explore the relationship between the microbiome and overall health. The company has developed an advanced microbiome profiling platform that utilizes deep metagenomics technology to analyze a wide range of microorganisms, including bacteria, fungi, viruses, and protists. This analysis creates a comprehensive map that links these microorganisms to various health conditions, symptoms, and food sensitivities. By interpreting microbiome test results, Jona aims to empower individuals to proactively manage their health through informed recommendations on diet, exercise, sleep, and other treatments, addressing the growing prevalence of chronic illnesses.
Emm
Seed Round in 2023
Emm is focused on creating innovative consumer health tools that empower individuals to manage their health effectively. The company has developed a wearable device aimed at enhancing reproductive health by providing users with biometric data that offers actionable insights into their unique reproductive profiles. This technology enables users and their healthcare providers to identify potential health issues and optimize reproductive health outcomes, thereby improving the overall quality of life. Emm's approach combines advanced technology with specialized knowledge to enhance personal health management.
Forta
Series A in 2023
Forta is a healthcare service provider that specializes in telehealthcare solutions aimed at children with autism. The company offers a personalized care approach through its platform, which incorporates artificial intelligence to create tailored programs that cater to the individual needs of each child. In addition to its telehealth services, Forta also provides applied behavior analysis therapy through online training programs, enhancing the accessibility and effectiveness of care for families.
Ellipsis Health
Series A in 2023
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
Eigen Therapeutics
Seed Round in 2023
Eigen Therapeutics is a biotechnology company dedicated to developing innovative therapies that enhance the detection and treatment of cancer. The company specializes in "priming" therapies, which help targeted treatments become more effective by addressing cancer heterogeneity and increasing the vulnerability of cancer cells, while simultaneously improving the resilience of healthy cells. Eigen is creating a high-throughput discovery platform that combines biology and engineering, utilizing proprietary machine learning algorithms to identify new drug classes and therapeutic approaches. This platform incorporates robotic systems, laboratory operations software, and machine learning analysis pipelines, all developed in-house. By focusing on combination therapeutics that improve efficacy and reduce toxicity, Eigen aims to provide physicians with access to novel treatments for patients with unmet medical needs, ultimately striving to enhance patient outcomes and save lives.
Basil Systems
Seed Round in 2023
Basil Systems operates a software-as-a-service platform that utilizes machine learning to analyze product, market, and regulatory data specifically for the medical device and pharmaceutical sectors. The platform offers critical analytics and insights that support strategic decision-making in product development, enhance product and supply chain quality, and minimize the risks associated with product recalls. Additionally, it aims to reduce the time required for regulatory approvals, ultimately enabling companies to deliver safe and effective products to consumers.
Fabric Health
Seed Round in 2023
Fabric Health is a healthcare service provider that operates within laundromats, focusing on enhancing the health and well-being of families. By utilizing the two hours that families spend at laundromats, the company offers access to local healthcare resources and information. This innovative approach allows families to engage with digital health services and improve their overall health experience while attending to their laundry needs.
Canid
Seed Round in 2023
Canid is a company focused on enhancing the vaccination process for pediatricians by streamlining vaccination record management. Its innovative scanning system reduces the need for manual data entry, facilitating the automatic upload of vaccination information into state registries. The company's dashboard and process tools provide administrative consulting, ensure vaccine margins, automate workflow, and manage vaccine inventory. This comprehensive approach allows state officials and pediatric practitioners to concentrate on their core responsibilities, ultimately improving efficiency in vaccination administration.
PulzAid
Pre Seed Round in 2023
PulzAid operates a managed marketplace focused on assisting injured workers in accessing a range of healthcare services, including telehealth, mobile imaging, and specialist consultations. By leveraging purpose-built software and established relationships with orthopedic surgeons and occupational medicine doctors, PulzAid aims to expedite treatment for employees, fostering quicker recovery and return to work. The company promotes a preventative approach to workplace injuries, offering services like on-demand video visits, in-person nurse visits, lab testing, and prescription services. This comprehensive model not only helps improve employee health outcomes but also assists employers in reducing costs associated with workplace injuries and workers' compensation claims.
Dentologie
Venture Round in 2023
Dentologie, founded by Dr. Hany Kurdi in 2013 and headquartered in Chicago, Illinois, aims to transform the dental experience by creating safe and inclusive environments for patients. The company specializes in urban dental solutions, providing a range of tech-enabled services that include general dentistry, Invisalign treatment, oral surgery, and cosmetic dentistry. Dentologie is committed to exceptional customer service and thoughtful design, ensuring that each patient receives personalized care and convenient access to dental solutions. By prioritizing compassion and competence, Dentologie seeks to change the perception of dental visits and enhance overall oral health.
Taro Health
Seed Round in 2023
Taro Health is a health insurance company that aims to provide affordable, relationship-based healthcare services to Americans. The company focuses on enhancing the interactions between doctors and patients, striving to reduce barriers in communication and care. By investing in initiatives that foster meaningful connections between healthcare providers and patients, Taro Health enables individuals to receive personalized and holistic treatments tailored to their specific healthcare needs.
eddii
Seed Round in 2023
Eddii is a health tracking application aimed at individuals living with diabetes, designed to enhance engagement and motivation in managing their health. The application features a virtual character that encourages users to record their daily wellness and adhere to healthy routines through gamification. By providing witty conversations and helpful tips, Eddii aims to make the process of tracking health enjoyable. Users receive weekly reports that highlight their progress, and the app rewards healthy practices and achievements with in-app incentives, fostering a supportive environment for better diabetes management.
VenoStent
Series A in 2023
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.
Ossium Health
Series C in 2023
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.
Upside Health
Seed Round in 2023
Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its mobile application, Ouchie. This application provides targeted educational content and rewards for achieving functional milestones, fostering a support system for patients. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to enhance care quality while minimizing the burden on healthcare providers. By empowering patients with data and social support, Upside Health aims to improve outcomes for chronic pain sufferers and create revenue-generating opportunities for healthcare practices.
3X Genetics
Pre Seed Round in 2023
3X Genetics specializes in developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company's technology focuses on screening for conditions such as myotonic dystrophy and other trinucleotide repeat disorders that lead to progressive muscle weakness. By offering these medical technologies, 3X Genetics enables healthcare professionals to proactively identify potential genetic issues, ultimately helping to prevent the birth of children affected by genetic diseases.
Betterleave
Seed Round in 2023
Betterleave is a digital health platform focused on providing personalized support to individuals dealing with grief and loss. The company combines human guidance with technology to engage members and connect them quickly to appropriate resources. Through a blend of individual grief counseling and group support, Betterleave offers evidence-based interventions tailored to the needs of those coping with bereavement. The platform also assists employers by offering bereavement benefits that help employees navigate the complexities of loss, including funeral and memorial arrangements, estate coordination, and financial planning. By fostering deep relationships with providers and integrating with insurers, Betterleave aims to deliver value-driven care that improves outcomes and enhances the overall experience for individuals during various stages of grief.
PharmaCCX
Seed Round in 2023
PharmaCCX, Inc. is a company that operates a market access platform designed to streamline the pricing and procurement of medicines for healthcare payers, thereby facilitating quicker patient access to necessary treatments. The platform primarily supports oncology pharmaceutical companies and various healthcare systems in the United States and Europe. Founded in 2017 and headquartered in Boston, Massachusetts, PharmaCCX also maintains offices in Stockholm, Sweden; San Mateo, California; and Zug, Switzerland. The company's software enhances the efficiency of market access teams within pharmaceutical companies and payers, enabling them to effectively plan, negotiate, and manage innovative payment models.
ROOK
Seed Round in 2023
ROOK is an API-first company focused on enhancing wellness through the integration of health data from various wearable devices. It provides a platform that allows applications and software to access meaningful health metrics and insights, thereby improving users' quality of life through sports, nutrition, and exercise. By facilitating the seamless integration, processing, and embedding of health data from numerous wearables and other sources, ROOK enables clients to obtain detailed evaluations of their exercise levels. This approach supports optimal training results and offers valuable recommendations tailored to individual health needs.
Adora Health
Seed Round in 2023
Adora Health is a digital health company focused on supporting women's health during menopause. It has developed a female health application that leverages natural language processing and artificial intelligence to provide personalized advice and resources. The platform offers a range of tools, including telehealth services and lifestyle recommendations, aimed at helping women manage their health, well-being, and nutrition during this transitional phase. By integrating advanced technology with user-friendly features, Adora Health seeks to empower women to take control of their health and improve their quality of life during menopause.
Oliva Health
Seed Round in 2023
Oliva Therapy is an online mental healthcare platform based in Barcelona, Spain, founded in 2020. It aims to make mental healthcare accessible, uncomplicated, and stigma-free for busy individuals. The platform allows users to book one-hour therapy sessions via real-time video calls with expert-curated therapists, who are matched to users based on their specific needs. By simplifying the process of seeking therapy, Oliva helps working professionals achieve their mental health goals while maintaining a better work-life balance. The focus on personalized matching and a hassle-free online experience distinguishes Oliva in the mental health sector.
Outbound AI
Seed Round in 2023
Outbound AI is a Seattle-based startup founded in 2021 that specializes in conversational AI tailored for the healthcare sector. The company focuses on automating and streamlining back-office administrative tasks within the revenue cycle, such as claim status checks, eligibility and benefits verification, explanation of benefits capture, and prior authorization processes. By leveraging cloud technologies and a real-time inference engine, Outbound AI enhances productivity and improves the work experience for healthcare professionals. The company's offerings feature AI agents specifically trained to operate within the standard workflows of healthcare roles, promoting greater accuracy and transparency. Outbound AI is supported by a team of experienced professionals from health and voice technology backgrounds, along with backing from prominent venture capital firms.
Forta
Series A in 2023
Forta is a healthcare service provider that specializes in telehealthcare solutions aimed at children with autism. The company offers a personalized care approach through its platform, which incorporates artificial intelligence to create tailored programs that cater to the individual needs of each child. In addition to its telehealth services, Forta also provides applied behavior analysis therapy through online training programs, enhancing the accessibility and effectiveness of care for families.
AlliConnect
Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
Mend
Series A in 2023
MEND is a life sciences company dedicated to advancing health and recovery through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that enhance patient outcomes in various contexts, including injury recovery, surgical recovery, aging, and physical performance. MEND's solutions have been widely adopted by hospitals, health systems, and professional sports teams across major leagues, as well as by the elite forces of the US Military. Through its commitment to ongoing research and development, MEND aims to empower caregivers and improve health outcomes for individuals facing diverse health challenges.
Synteny.Ai
Seed Round in 2023
Synteny.Ai Syntney decodes the signals of immune repertoires to help biotech research and pharma companies with disease discoveries.
DropStat
Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.
Pathfinder Health
Seed Round in 2023
Pathfinder Health is focused on enhancing child development for children aged 0-5 through its evidence-based clinical tool. This pediatric application aids parents and caregivers in monitoring developmental milestones, encouraging cognitive, physical, social, emotional, and communication growth through play. It facilitates communication with healthcare providers, allowing for earlier diagnoses of potential developmental issues. The app offers step-by-step guidance tailored to a child's current stage of development and connects users to additional resources, including developmental activities, articles, parenting tips, and local early intervention services. By providing these tools, Pathfinder Health empowers families to track their child's progress and seek timely intervention when necessary.
Iolyx Therapeutics
Series A in 2023
Iolyx Therapeutics is a biotechnology company focused on developing solutions for ocular diseases. Operating at the intersection of immunology and ophthalmology, the company aims to transform the standard of care for these conditions. Iolyx Therapeutics utilizes an innovative platform that provides tailored formulations for precise delivery to targeted eye tissues. Its products are designed to address ocular inflammation directly at its source, affecting both the front and back of the eye. This approach seeks to enhance efficacy, safety, and convenience for patients suffering from various ocular conditions.
Rensair
Series A in 2023
Rensair specializes in the development of portable hospital-grade air purifiers that aim to provide clean air in various environments. Initially designed for Scandinavian hospitals, their air purification technology incorporates high-efficiency particulate air (HEPA13) filters and ozone-free ultraviolet light, which effectively eliminates airborne viruses, including the coronavirus. Rensair's products are utilized in a range of settings, including hospitals, schools, and care homes, ensuring optimum indoor air quality and promoting health and safety in populated spaces. Trusted by businesses globally, Rensair's solutions are designed to enhance the well-being of individuals by improving the air quality they breathe.
Work & Mother
Venture Round in 2023
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.
Andromeda Surgical
Seed Round in 2023
Andromeda Surgical is a developer of autonomous robots designed to enhance the consistency, accuracy, and efficiency of surgical procedures. The company's open platform focuses on urologic procedures that have demonstrated superior outcomes but face challenges in widespread adoption due to technical complexities. By addressing these difficulties, Andromeda Surgical aims to empower surgeons to perform various procedures at a level typically achieved only by experts, thereby improving patient care and surgical success rates.
Mign
Seed Round in 2023
Mign specializes in developing personalized medical devices for musculoskeletal health, focusing on digitally tailored orthopedic products. The company employs proprietary technology that transforms complex three-dimensional body data into customized wearable items. These products feature breathable three-dimensional patterns designed to meet individual physical needs, effectively addressing various orthopedic issues. Mign aims to revolutionize the design, engineering, manufacturing, and delivery processes of medical devices, contributing to a more digital and sustainable future in healthcare.
Jona
Seed Round in 2023
Jona is a technology startup focused on leveraging artificial intelligence to explore the relationship between the microbiome and overall health. The company has developed an advanced microbiome profiling platform that utilizes deep metagenomics technology to analyze a wide range of microorganisms, including bacteria, fungi, viruses, and protists. This analysis creates a comprehensive map that links these microorganisms to various health conditions, symptoms, and food sensitivities. By interpreting microbiome test results, Jona aims to empower individuals to proactively manage their health through informed recommendations on diet, exercise, sleep, and other treatments, addressing the growing prevalence of chronic illnesses.
Mantra Health
Series A in 2023
Mantra Health is a digital mental healthcare company focused on providing mental health services specifically for university students. The company has developed a platform that includes a proprietary Collaboration Portal, allowing universities to create tailored telemental health programs that enhance clinical outcomes and decrease the time students wait to access care. Mantra Health's platform offers a range of services, including psychiatric care, online assessments, initial video consultations, and personalized care plans, all designed to facilitate easy and comfortable treatment for students in their own homes. This approach aims to improve the overall mental health of students across various educational institutions.
Options MD
Seed Round in 2023
Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The platform utilizes artificial intelligence to match patients with innovative depression care options provided by psychiatric experts. By streamlining the referral process to in-house specialists, Options MD enables patients to access appropriate medical care more efficiently, aiming to improve their treatment outcomes.
Bionic Health
Seed Round in 2023
Bionic Health is a digital healthcare company focused on providing preventative health services, particularly for individuals experiencing chronic pain. The company has developed a platform that utilizes frequent diagnostics and machine learning to create personalized treatment plans. This approach emphasizes slowing down the aging process and offers patients tailored insights derived from ongoing assessments. By implementing an iterative journey, Bionic Health enables users to identify their unique health needs and make impactful lifestyle changes over time. Additionally, patients benefit from closely monitored preventative care throughout the year, enhancing their overall well-being.
Womaness
Seed Round in 2023
Womaness is an e-commerce platform that specializes in modern menopause products, aiming to transform the conversation around this natural life stage. The company offers a diverse range of feminine care items designed to address various symptoms associated with menopause, including hot flashes, sleep disturbances, and skin changes. Womaness emphasizes the importance of providing solutions that are free from harmful additives such as parabens, phthalates, sulfates, and hormones, ensuring that its products are vegan and gluten-free. In addition to its product offerings, Womaness fosters a supportive community that shares trusted advice and experiences, empowering women to navigate menopause with confidence and ease.
Dimension Inx
Series A in 2023
Dimension Inx Corp. focuses on designing and developing three-dimensional (3D) printable materials and painted objects for research and commercial applications. The company specializes in creating regenerative microenvironments that aid the body in self-healing. Its biomaterials platform incorporates a complex interplay of material composition, microstructure, and microarchitecture to enhance biofunctionality. Dimension Inx offers a range of products, including Hyperelastic Bone for bone regeneration, 3D printable elastomers, bioactive ceramics, and solutions for soft tissue regeneration. Founded in 2016 and based in Chicago, Illinois, the company aims to provide innovative therapeutic products that restore tissue and organ function, potentially reducing the need for organ transplantation through advanced bio-fabrication processes.
Featureform
Seed Round in 2023
Featureform develops machine learning tools specifically for pharmaceutical and biotechnology companies. The company offers an open-source virtual feature store that enables data scientists to define, manage, and serve machine learning features throughout their organizations. Its platform provides a unified interface to connect, transform, and join both streaming and batch data. Featureform facilitates the discovery and integration of features created by various teams, allowing them to share and enhance their models. Additionally, the platform includes capabilities to monitor and analyze features, as well as to freeze them, which allows teams to concentrate on building models to support their data pipelines effectively.
Precision Neuroscience
Series B in 2023
Precision Neuroscience is a company focused on developing advanced brain-computer interface technology aimed at offering innovative treatments for the approximately one billion individuals worldwide affected by neurological disorders. Founded in 2021 and based in New York, the company's technology is characterized by its minimally invasive design, safety for removal, and capacity for processing substantial data. This platform enables medical professionals to establish a direct connection between the human brain and artificial intelligence, potentially transforming the landscape of neurological care.
Gilgamesh Pharmaceuticals
Series B in 2022
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.
Eigen Therapeutics
Seed Round in 2022
Eigen Therapeutics is a biotechnology company dedicated to developing innovative therapies that enhance the detection and treatment of cancer. The company specializes in "priming" therapies, which help targeted treatments become more effective by addressing cancer heterogeneity and increasing the vulnerability of cancer cells, while simultaneously improving the resilience of healthy cells. Eigen is creating a high-throughput discovery platform that combines biology and engineering, utilizing proprietary machine learning algorithms to identify new drug classes and therapeutic approaches. This platform incorporates robotic systems, laboratory operations software, and machine learning analysis pipelines, all developed in-house. By focusing on combination therapeutics that improve efficacy and reduce toxicity, Eigen aims to provide physicians with access to novel treatments for patients with unmet medical needs, ultimately striving to enhance patient outcomes and save lives.
SendaRide
Series B in 2022
SendaRide, Inc. is a company based in Oklahoma City, Oklahoma, that specializes in providing non-emergency medical transportation services. Founded in 2016, SendaRide operates a platform tailored for the healthcare industry, enabling users to book both on-demand and pre-scheduled transportation. The application offers customized transport solutions for non-emergency medical patients, the elderly, and children, allowing users to find suitable transportation options easily. Additionally, the platform includes features such as GPS monitoring, live video feeds during transportation, and the ability to rate drivers or caretakers based on the services received. This comprehensive approach ensures that patients can reach their destinations safely and reliably.
Axoft
Seed Round in 2022
Axoft is a company focused on developing advanced implantable electronics that enhance communication between the brain and machines. Its flagship technology consists of bioinspired implants made from ultra-flexible plastic mesh, which provides a softer alternative to traditional plastic and silicone implants. This innovative design allows for scalability and the integration of multiple sensors within a single implant, closely matching the brain's mechanical properties. Axoft's implants aim to improve clinical outcomes for patients suffering from neurodegenerative conditions, such as Parkinson's disease, thereby transforming individual health and overall human experience.
SURGE Therapeutics
Series A in 2022
SURGE Therapeutics is dedicated to enhancing cancer patient survival through innovative approaches in immunotherapy. The company has developed a proprietary injectable biodegradable hydrogel designed for the prolonged and localized release of cancer immunotherapy following surgical tumor resection. By targeting the administration of treatment to specific areas at the optimal time, SURGE Therapeutics aims to improve the effectiveness of immunotherapy, allowing for both intravenous and intratumoral injections. This technology seeks to disrupt traditional cancer treatment paradigms and provide better outcomes for patients.
Brave Health
Series C in 2022
Brave Health operates a virtual clinic that provides telehealth services focused on mental health and addiction treatment. Established in 2017 in Miami, Florida, the company specializes in behavioral health, offering a range of services including counseling, therapy, psychiatry, and medication management, which encompasses medication-assisted treatment. This telehealth approach allows patients to receive comprehensive care for various conditions related to mental health and substance use disorders, facilitating greater access to necessary treatment.
PathSpot
Series A in 2022
PathSpot Technologies, Inc., established in 2017 and headquartered in New York City, specializes in food safety solutions. The company develops and manufactures a unique system that uses a proprietary algorithm to analyze fluorescent light, enabling it to scan employees' hands and detect pathogens that cause food-borne illnesses. This technology helps restaurants and their customers mitigate the risk of food-borne illnesses by providing instant, invisible signs of harmful bacteria and viruses.
Willow
Series D in 2022
Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.
Scratch
Series C in 2022
Scratch is a financial technology company that specializes in payment processing, patient financing, and communication tools tailored for veterinary and medical practices. Its platform is utilized by approximately half of all veterinary clinics in the United States, facilitating efficient interactions and transactions between practices and their clients. Scratch's patient financing solution offers clients, including pet owners, a guaranteed financing offer in as little as 60 seconds, helping them manage medical expenses. Additionally, Scratch's payment processing tools integrate with popular practice management systems, enhancing the checkout experience for both patients and practices. This comprehensive approach supports various medical and dental practices in accessing modern financial solutions effectively.
Remedial Health
Seed Round in 2022
Remedial Health operates as a wholesale distributor of medicine, catering to the vast network of approximately one million pharmacies and hospitals across Africa. The company addresses the prevalent inefficiencies in the healthcare supply chain, where providers often depend on open-air markets to acquire pharmaceuticals, leading to risks of counterfeit products. By offering a pharmacy operations and procurement management platform, Remedial Health enhances business-to-business access to medications. This platform incorporates technology that simplifies the ordering process and facilitates direct access to retail medicines from manufacturers or distributors, thereby improving workflow management and ensuring a more reliable supply of genuine medications for healthcare providers.
Kalderos
Venture Round in 2022
Kalderos, Inc. is a company that specializes in drug discount management solutions for various stakeholders in the U.S. healthcare system, including providers, manufacturers, and payers. Established in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and streamline the complex coordination of drug discount programs. The platform employs advanced models and machine learning to identify and resolve non-compliance issues, detecting inconsistencies that traditional methods often miss. By providing data management capabilities and customizable insights, Kalderos enables clients to enhance their processes for claims verification, dispute resolution, and discount monitoring, ultimately reducing waste and improving operational efficiency.
Fabric Health
Seed Round in 2022
Fabric Health is a healthcare service provider that operates within laundromats, focusing on enhancing the health and well-being of families. By utilizing the two hours that families spend at laundromats, the company offers access to local healthcare resources and information. This innovative approach allows families to engage with digital health services and improve their overall health experience while attending to their laundry needs.
Abingdon Software Group
Seed Round in 2022
Abingdon Software Group specializes in developing critical software solutions for various industries experiencing rapid digital transformation. The company's mission-critical platform serves multiple sectors, including agriculture, shipping, healthcare, logistics, local authorities, resorts, industrial operations, and construction. By providing tailored applications, Abingdon Software Group enables businesses to enhance their essential operations and adapt to the evolving demands of their respective markets.
Health Note
Series A in 2022
Health Note is an AI chatbot platform that streamlines the process of collecting patient information and creating physician notes, thereby enhancing clinic workflows. Founded in 2018 and based in San Francisco, California, the platform allows patients to engage in their own care by providing pre-visit information through a simple SMS link, eliminating the need for app downloads or sign-ins. This frictionless, platform-agnostic solution integrates seamlessly with electronic medical record systems, facilitating the documentation of physician-patient interactions and improving overall healthcare efficiency.
Moving Analytics
Series A in 2022
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Swing Therapeutics
Series A in 2022
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.
Sesame
Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.
Quadrant Health
Pre Seed Round in 2022
Quadrant Health, founded in 2021 by Krishna Gorrepati and Anin Sayana, specializes in providing real-time analysis of electronic health records (EHR) and patient messaging data. The company has developed a cloud-based disease prediction platform that employs machine learning algorithms to identify potential health risks, such as infections and injuries, before symptoms manifest. This innovative approach enables healthcare providers to proactively manage patient care, enhancing their ability to prevent harm and improve overall patient outcomes. By focusing on early detection, Quadrant Health aims to transform preventative medicine and support healthcare professionals in delivering more effective care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.